Accelerate Diagnostics to Present at the 37th Annual Growth Stock Conference hosted by William Blair & Company
June 07, 2017 18:06 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., June 07, 2017 (GLOBE NEWSWIRE) -- Lawrence Mehren, president and chief executive officer of Accelerate Diagnostics, will present at the 37th Annual Growth Stock Conference hosted by...
Accelerate Diagnostics announces sizeable release of data at ASM Microbe 2017
May 30, 2017 10:30 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., May 30, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced that new data from 11 healthcare institutions covering more than 1,200 samples will be presented at...
Accelerate Diagnostics Announces Closing of $79.3 Million Upsized Offering
May 15, 2017 17:14 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., May 15, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced the closing of its previously announced underwritten public offering of 2,750,000 shares of its...
Accelerate Diagnostics Announces Pricing of Upsized Public Offering of Common Stock
May 09, 2017 21:59 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., May 09, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) today announced the pricing of an underwritten public offering of 2,750,000 shares of its common stock,...
Accelerate Diagnostics Announces Proposed Public Offering of Common Stock
May 08, 2017 16:14 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., May 08, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) today announced that it has commenced an underwritten public offering of 2,500,000 shares of its common...
Accelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017
May 03, 2017 16:05 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., May 03, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced preliminary financial results for the quarter ending March 31, 2017 including signed customer evaluation...
Accelerate Diagnostics Schedules Call to Review First Quarter 2017 Results for May 3rd
April 18, 2017 17:53 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., April 18, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Wednesday, May 3rd, 2017 to discuss its first quarter 2017 financial...
Accelerate Diagnostics Names Tom Brown to Board of Directors
March 15, 2017 12:15 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., March 15, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced the election of Tom Brown to the company’s board of directors. His appointment is effective March 14,...
Accelerate Diagnostics Receives FDA Marketing Authorization for the Accelerate Pheno™ System and Accelerate PhenoTest™ BC Kit
February 23, 2017 21:45 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Accelerate) today announced that the U.S. Food and Drug Administration has granted the de novo request to market the...
Accelerate Diagnostics to Report Preliminary Fourth Quarter and Full Year 2016 Results on February 27th
February 23, 2017 16:19 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced it will report preliminary fourth-quarter and full year 2016 financial results on Monday, February 27th,...